Finnish startup AIATELLA has raised €2m ($2.27m) in financing to develop and scale its cardiovascular imaging technology powered by AI. The investment will support the company in conducting clinical ...

PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase ...

On Philadelphia’s North Broad Street, Dr. Jon George, along with his business partner, Dr. Vincent Varghese, is introducing sophisticated interventional cardiology technology that he says could change ...

Angiography is a widely used medical imaging technique that allows medical researchers and doctors to capture the vascular network (i.e., blood vessels) using contrast agents, substances that ...

Evident Vascular, Inc., is developing an advanced intravascular ultrasound (IVUS) platform designed to optimize vascular imaging for peripheral and coronary interventions.

The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to ...

A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods ...

University Hospitals recently announced that its Harrington Heart & Vascular Institute is expanding advanced cardiac care and ...

Introduction The global vascular access device market is undergoing substantial expansion, propelled by the rising incidence of chronic conditi ...

MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for ...

Evident Vascular, Inc., is developing an advanced intravascular ultrasound (IVUS) platform designed to optimize vascular imaging for peripheral and coronary interventions.

PITTSBURGH, June 21, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase its presence at the St. Louis Wound ...